Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion type Assertion NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_head.
- NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion description "[Genetic polymorphisms in genes related to metabolism and action sites of gemcitabine showed associations with the therapeutic efficacy, in terms of OS, TTP and disease progression in pancreatic cancer patients treated with gemcitabine-based chemotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_provenance.
- NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion evidence source_evidence_literature NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_provenance.
- NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion SIO_000772 22838950 NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_provenance.
- NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion wasDerivedFrom befree-20140225 NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_provenance.
- NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_assertion wasGeneratedBy ECO_0000203 NP902563.RADOLNRyDbZuRgr7wNGg81eWKNwC9IBz_U-NXIuhE44rA130_provenance.